美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
83008-063-30	83008-063	HUMAN PRESCRIPTION DRUG	GABAPENTIN	Gabapentin	TABLET	ORAL	20240610	N/A	ANDA	ANDA214957	Quality Care Products, LLC	GABAPENTIN	600 mg/1	30 TABLET in 1 BOTTLE (83008-063-30)
83008-063-60	83008-063	HUMAN PRESCRIPTION DRUG	GABAPENTIN	Gabapentin	TABLET	ORAL	20240610	N/A	ANDA	ANDA214957	Quality Care Products, LLC	GABAPENTIN	600 mg/1	60 TABLET in 1 BOTTLE (83008-063-60)
83008-063-90	83008-063	HUMAN PRESCRIPTION DRUG	GABAPENTIN	Gabapentin	TABLET	ORAL	20240610	N/A	ANDA	ANDA214957	Quality Care Products, LLC	GABAPENTIN	600 mg/1	90 TABLET in 1 BOTTLE (83008-063-90)
68788-8476-1	68788-8476	HUMAN PRESCRIPTION DRUG	GABAPENTIN	Gabapentin	TABLET	ORAL	20230705	N/A	ANDA	ANDA214957	Preferred Pharmaceuticals Inc.	GABAPENTIN	600 mg/1	100 TABLET in 1 BOTTLE (68788-8476-1)
68788-8476-9	68788-8476	HUMAN PRESCRIPTION DRUG	GABAPENTIN	Gabapentin	TABLET	ORAL	20230705	N/A	ANDA	ANDA214957	Preferred Pharmaceuticals Inc.	GABAPENTIN	600 mg/1	90 TABLET in 1 BOTTLE (68788-8476-9)
68788-8476-3	68788-8476	HUMAN PRESCRIPTION DRUG	GABAPENTIN	Gabapentin	TABLET	ORAL	20230705	N/A	ANDA	ANDA214957	Preferred Pharmaceuticals Inc.	GABAPENTIN	600 mg/1	30 TABLET in 1 BOTTLE (68788-8476-3)
68788-8476-6	68788-8476	HUMAN PRESCRIPTION DRUG	GABAPENTIN	Gabapentin	TABLET	ORAL	20230705	N/A	ANDA	ANDA214957	Preferred Pharmaceuticals Inc.	GABAPENTIN	600 mg/1	60 TABLET in 1 BOTTLE (68788-8476-6)
68788-8476-8	68788-8476	HUMAN PRESCRIPTION DRUG	GABAPENTIN	Gabapentin	TABLET	ORAL	20230705	N/A	ANDA	ANDA214957	Preferred Pharmaceuticals Inc.	GABAPENTIN	600 mg/1	120 TABLET in 1 BOTTLE (68788-8476-8)
68788-8488-8	68788-8488	HUMAN PRESCRIPTION DRUG	GABAPENTIN	Gabapentin	TABLET	ORAL	20230721	N/A	ANDA	ANDA214957	Preferred Pharmaceuticals Inc.	GABAPENTIN	600 mg/1	120 TABLET in 1 BOTTLE (68788-8488-8)
68788-8488-9	68788-8488	HUMAN PRESCRIPTION DRUG	GABAPENTIN	Gabapentin	TABLET	ORAL	20230721	N/A	ANDA	ANDA214957	Preferred Pharmaceuticals Inc.	GABAPENTIN	600 mg/1	90 TABLET in 1 BOTTLE (68788-8488-9)
68788-8488-1	68788-8488	HUMAN PRESCRIPTION DRUG	GABAPENTIN	Gabapentin	TABLET	ORAL	20230721	N/A	ANDA	ANDA214957	Preferred Pharmaceuticals Inc.	GABAPENTIN	600 mg/1	100 TABLET in 1 BOTTLE (68788-8488-1)
68788-8488-3	68788-8488	HUMAN PRESCRIPTION DRUG	GABAPENTIN	Gabapentin	TABLET	ORAL	20230721	N/A	ANDA	ANDA214957	Preferred Pharmaceuticals Inc.	GABAPENTIN	600 mg/1	30 TABLET in 1 BOTTLE (68788-8488-3)
68788-8488-6	68788-8488	HUMAN PRESCRIPTION DRUG	GABAPENTIN	Gabapentin	TABLET	ORAL	20230721	N/A	ANDA	ANDA214957	Preferred Pharmaceuticals Inc.	GABAPENTIN	600 mg/1	60 TABLET in 1 BOTTLE (68788-8488-6)
31722-166-05	31722-166	HUMAN PRESCRIPTION DRUG	GABAPENTIN	Gabapentin	TABLET	ORAL	20211001	N/A	ANDA	ANDA214957	Camber Pharmaceuticals, Inc.	GABAPENTIN	600 mg/1	500 TABLET in 1 BOTTLE (31722-166-05)
31722-167-01	31722-167	HUMAN PRESCRIPTION DRUG	GABAPENTIN	Gabapentin	TABLET	ORAL	20211001	N/A	ANDA	ANDA214957	Camber Pharmaceuticals, Inc.	GABAPENTIN	800 mg/1	100 TABLET in 1 BOTTLE (31722-167-01)
31722-167-05	31722-167	HUMAN PRESCRIPTION DRUG	GABAPENTIN	Gabapentin	TABLET	ORAL	20211001	N/A	ANDA	ANDA214957	Camber Pharmaceuticals, Inc.	GABAPENTIN	800 mg/1	500 TABLET in 1 BOTTLE (31722-167-05)
31722-166-01	31722-166	HUMAN PRESCRIPTION DRUG	GABAPENTIN	Gabapentin	TABLET	ORAL	20211001	N/A	ANDA	ANDA214957	Camber Pharmaceuticals, Inc.	GABAPENTIN	600 mg/1	100 TABLET in 1 BOTTLE (31722-166-01)
68788-8468-1	68788-8468	HUMAN PRESCRIPTION DRUG	GABAPENTIN	Gabapentin	TABLET	ORAL	20230626	N/A	ANDA	ANDA214957	Preferred Pharmaceuticals Inc.	GABAPENTIN	800 mg/1	100 TABLET in 1 BOTTLE (68788-8468-1)
68788-8468-9	68788-8468	HUMAN PRESCRIPTION DRUG	GABAPENTIN	Gabapentin	TABLET	ORAL	20230626	N/A	ANDA	ANDA214957	Preferred Pharmaceuticals Inc.	GABAPENTIN	800 mg/1	90 TABLET in 1 BOTTLE (68788-8468-9)
68788-8468-3	68788-8468	HUMAN PRESCRIPTION DRUG	GABAPENTIN	Gabapentin	TABLET	ORAL	20230626	N/A	ANDA	ANDA214957	Preferred Pharmaceuticals Inc.	GABAPENTIN	800 mg/1	30 TABLET in 1 BOTTLE (68788-8468-3)